Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications (Q38663736)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications
scientific article

    Statements

    Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications (English)
    1 reference
    Jothilatha Krishnamoorthy
    1 reference
    Kamindla Rajesh
    1 reference
    Farzaneh Mirzajani
    1 reference
    Polixenia Kesoglidou
    1 reference
    Andreas I Papadakis
    1 reference
    Antonis E Koromilas
    1 reference
    8 January 2014
    1 reference
    13
    1 reference
    5
    1 reference
    801-806
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit